Rising interest in CRISPR treatments

Treatments using CRISPR technology are emerging as one of the hottest medical trends in the United States – and the FDA is doing its best to promote the development.

Krönika: Collaboration across borders

Before you choose a CRO

– We are a small company and it is very important for us to maintain our core competence within development of novel nanomaterials, Tove Sivik Sonne, Head of De...

Column: Why there cannot be a complete cure for cancer – but there is certainly another way!

"Is there a new way we need to be thinking about how to prevent cancer?" Lucy Robertshaw reflects upon which is the smartest way to beat cancer.

Astra Zeneca försäkrar vaccinets säkerhet

Enligt bolaget orsakar deras vaccin inte fler blodproppar än andra covid-19 vaccin.

Swedish and Danish Life Science – are there still untapped synergies?

not be better. A one-day conference on ongoing collaborations, new directions and required future investment will held on April 2nd at Medicon Village in Lund.

Drug development creates new challenges for regulators

Investments worth 40 billion in the Öresund region – “A huge investment wave”

A new report reveals that medical companies in the Oresund region are investing like never before.

Pharma-on-Demand

Make or buy? That is the question that the pharma world has been asking more and more in the last couple of decades. Pernille Hemmingsen is moderator at Pharma ...

Studie: Klent stöd för nyttan av många nya cancerläkemedel

Nya cancerläkemedel lanseras i strid ström, men sker det för fort? Enligt en studie från Göteborgs universitet saknas det i många fall vetenskapligt stöd för at...

Snabb installation och rätt reglering

AS-DPX från SMC är en smart avluftare/ljuddämpare med reglerfunktion och indikator för enkel och korrekt inställning av cylinderhastigheten.

Claims of life science companies fleeing abroad is a myth according to survey

The claim that life science companies are moving abroad is exaggerated. In fact, only a tiny percentage is leaving the country, according to a survey.

Helena Strigård: The rise of the community

Sweden Bio´s CEO is looking back at the last decade of development in the industry. Something has shifted in the interdependence between small and larger companies.

The Swedish Research Council gets go-ahead for more long-term funding

Following a government decision, the Swedish Research Council will soon be able to approve ten-year grant periods for funding research infrastructure, which may...

Webinar: Clinical evaluation and clinical investigation of medical devices

Whether you are a small medtech company or a large one, this webinar is a must-attend for anyone curious about how clinical studies on medical devices are conducted.

Vertex betalar 52 miljarder för bolag inom autoimmuna sjukdomar

Amerikanska Vertex Pharmaceuticals köper biotechbolaget Alpine Immune Sciences för 4,9 miljarder dollar, motsvarande drygt 52 miljarder kronor.

Första genterapin för svår hemofili A godkänd i EU: "Ett medicinsk genombrott"

Den första genterapin för behandling av vuxna med svår hemofili A har fått grönt ljus av EU-kommissionen.

Swedish Healthtech Company 1928 Pushing Forward

The full service analytics platform is expanding the business.

How to become globally competitive

Here Gunilla Osswald from BioArctic share her experience of scaling up and be competative on the global arena.

Ossiform: Quality control of 3D printed bone implants

Ossiform chose the GOM Scan 1.

Forskare undersöker samband mellan covid-19 och demens

"Hjärndimma" är ett av de symtom som beskrivits efter infektion med sars-cov-2. Forskare i Indien pekar på att demensrelaterade besvär kan tillta hos patienter ...

Fullt godkännande i EU för Calliditas njurläkemedel – "Viktig händelse"

Calliditas läkemedel Kinpeygo har fått ett fullständigt godkännande från EU-kommissionen för behandling av vuxna med njursjukdomen IgA-nefropati, IgAN.

Anna Törner: You won’t find this many Concorde projects anywhere else

"Suddenly Concorde projects seem reasonable in life science because it´s about life and death", writes Anna Törner in a column.

The Swedish Academy of Sciences: “We have too many researchers”

Sweden does not need more researchers, but it does need better ones. According to the Royal Swedish Academy of Sciences, funding should be distributed to favour excellence.